# The Medical Travel Company

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/the-medical-travel-company

- Industry: Healthcare
- Headquarters: London, UK
- Website: www.themedicaltravelcompany.com
- Total disclosed funding: $4.5M
- Latest round: Seed (Oct 7, 2025)
- Investors on record: 5

## About

The Medical Travel Company, based in the UK, specializes in facilitating medical tourism, connecting patients with esteemed healthcare facilities in India for various treatments like orthopaedics and fertility services.Founded in 2024, The Medical Travel Company connects UK patients with healthcare services in India, providing a structured medical tourism experience. The company has successfully closed its first deal, raising EUR 3.8 million in a Seed round led by Nexus Venture Partners on October 7, 2025, with participation from 1947 Rise, Kriscore Capital, and PeerCheque. No significant pivots have been noted in its business strategy since inception, and it operates from London, UK, with plans to expand internationally.The Medical Travel Company (TMTC) specializes in facilitating medical tourism by connecting UK patients with top-tier healthcare facilities in India. Their core offerings include a range of medical treatments such as orthopaedic surgeries (including hip and knee replacements), dental procedures (both corrective and cosmetic), and fertility treatments, including personalized IVF support. By providing a structured pathway for patients, TMTC ensures comprehensive support throughout the medical journey—from initial consultations with UK and Indian doctors to recovery in premium aftercare facilities. The company predominantly serves UK patients seeking timely and affordable healthcare solutions, and they are strategically targeting the growing markets of Europe and the Middle East, capitalizing on the increasing demand for cost-effective medical care without compromising quality.TMTC generates revenue through a transactional model where patients pay for medical treatments and associated services directly. Each patient engagement typically involves a comprehensive package that includes the treatment, accommodation, and aftercare services, structured to enhance the overall experience while ensuring quality care. For instance, hip replacement surgery is offered at a significant cost advantage compared to typical UK private care prices, enhancing TMTC's appeal to potential clients. The company also provides a 12-month post-treatment insurance plan, further integrating its offerings and supporting ongoing patient care. Revenue is primarily derived from direct-to-consumer transactions, with patients paying upfront for the complete service package, thereby streamlining the purchasing process and enhancing patient satisfaction.In October 2025, The Medical Travel Company raised EUR 3.8 million in Seed funding led by Nexus Venture Partners, which will be utilized to expand clinical partnerships in the UK, establish certified treatment pathways, and build technology for complete medical records to support continuity of care. The company is also looking to introduce new product offerings that enhance its service packages and aims to expand into the European and Middle Eastern markets by the end of 2026.

## Funding rounds

- Seed, Oct 7, 2025, $4.5M — Nexus Venture Partners, 1947 Rise, PeerCheque, Kriscore Capital, 4Cast

## Investors

- Nexus Venture Partners (https://capitalatlas.ai/funds/nexus-venture-partners) — Seed
- 1947 Rise (https://capitalatlas.ai/funds/1947-rise) — Seed
- PeerCheque (https://capitalatlas.ai/funds/peercheque) — Seed
- Kriscore Capital (https://capitalatlas.ai/funds/kriscore-capital) — Seed
- 4Cast (https://capitalatlas.ai/funds/4cast) — Seed